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The use of lung progenitors for regenerative medicine appears promising, albeit their biology has not been fully 
understood. Recently, particular attention has been paid to discover the regional population of stem/progenitor cell 
population mediating epithelial homeostasis in small airways  called bronchioles as commonly injured in a variety of 
inflammatory clinical settings. In small airways, a subset of club cells is best understood as bronchiolar progenitors that 
self-renewal over the long term and that can differentiate into differentiated club cells and ciliated cells. Here I enable to 
isolate the subsets of club cells termed as bronchilar progenitors, and distinguish their ability to modulate lung 
inflammation. In the mouse-inflammatory models, transfer of bronchiolar progenitors significantly reduced inflammation 
as compared to the transfer of differentiated club cells. Furthermore, I found anti-inflammatory attributes of bronchiolar 
progenitors that are sorted as a distinct subset of mouse club cells and express secretory leukocyte protease inhibitor 
(SLPI). Notably, the impaired SLPI expression increased the number of bronchiolar progenitors and decreased lung 
inflammation in knockout and knockdown mice. I determined a transcriptional profile for the bronchiolar progenitors of 
Slpi-deficient mice, and identified syndecan 4 whose expression elevated as compared to those of wild-type mice. 
Systemic administration of recombinant syndecan-4 protein caused a substantial increase in the number of bronchiolar 
progenitors with a concomitant attenuation of both airway and alveolar inflammation induced by naphthalene and 
bleomycin, respectively. The syndecan 4 administration also resulted in activation of the Keap1-Nrf2 antioxidant 
pathway in the lung cells, which critically involved in the therapeutic responses to the syndecan 4 treatment. Moreover, 
in 3D culture, the presence of syndecan 4 bolstered differentiatited club cells to undergo Nrf2-dependent transition into 
bronchiolar progenitors. Our observations reveal that phenotypic switches between club cells and bronchiolar 
progenitors are under Nrf2-mediated control of syndecan 4 and this may offer new therapeutic approaches in 
inflammatory lung diseases. 
